The rheumatism of the moon says the twilight of the joints is repeated? It could have happened!

“My joints are swollen, and I can’t sleep at night, is it rheumatism?”

Many may have experienced similar problems.

The rheumatism arthritis, also known by the Chinese doctor as “paralytic”, “rubber knee”, is a self-immunological disease characterized by the emergence of a rhinitis disease, with the main symptoms of morning rigidity, swelling of the joint and deformity.

But you know what? There is also a disease, which is also characterized by repeated corrosive pain, but is prone to misdiagnosis as rheumatism, which is retributive rheumatism.

What’s a ruby?

Retaliated rheumatism, also known as relapsing rheumatism, is a clinical syndrome characterized by short-term outbreaks of acute arthritis and arthritis around it.

Often with single joints, multiple joints can be quickly attacked within hours, with inflammations such as red and swollen fever, and all symptoms can disappear completely for hours or days after the onset of the disease, without any trace, but repeatedly, with about 30 to 40 per cent of the patients being able to move to rheumatism.

There are currently no uniform criteria for the diagnosis of retaliated rheumatism, which relies mainly on clinical performance and the exclusion of other diseases. According to the classification criteria proposed by Guerne and Weisman in 1992, the diagnostic points for retinal rheumatism include:

• Repeated and sudden outbreaks of single or small joint inflammation, or arthritis on the side of the joint, lasting for more than six months;

• At least one attack was confirmed by a physician;

• Three joints in the series;

• No erosion change in video science;

• Exclusion of other arthritis.

Distinction from rheumatism

Although the symptoms of rheumatism are similar to those of rheumatism, the fact remains that there is a greater difference between the two.

(b) Periphery: Retaliated rheumatism is mostly a single-sided small joint with no symmetry, whereas rheumatism is a double symmetrical disease;

Long epidemiology: Retaliated rheumatism occurs for a relatively short period of time and can be mitigated in hours to days, leaving no after-effects; and long epidemiology requires active treatment to control the condition.

Laboratory indicators: Retaliated rheumatism during the onset period may increase in inflammation indicators such as erythrocyte deposition (ESR), C Reaction Protein (CRP) etc., but most of the periods of onset are normal, while blood sunk in rheumatism, CRP, etc. can increase.

In addition, some retraced rheumatism patients may have a type of rheumatism factor (RF) or anticyclic mercurate (CCP) anti-positive but have a lower positive than rheumatism.

We can’t afford Chinese medicine.

When you look at the top, many people think that if you don’t treat it and the symptoms are self-resolved, do you think you don’t need to control it?

Dr. Wong told us: of course not!

Although the symptoms can be alleviated on their own, the disease has recurring symptoms. If unchecked, the frequency of outbreaks is increasing, which can cause greater suffering and inconvenience to the lives of patients and have a significant impact on their lives and work.

In addition, we have mentioned above that some of the retinal rheumatism can eventually develop into rheumatism, which is a mixed story.

It is a matter of concern that, once turned into rheumatism, it means that the patient ‘ s condition has increased.

Happily, retributive rheumatism is not yet rheumatism, and can be controlled through drug treatment and dietary adjustments, reducing the onset, reducing the likelihood of development and keeping the condition at a lighter stage.

So if you find that your symptoms sound similar to retweed rheumatism, it is recommended that you visit the hospital as soon as possible.

For the treatment of retaliated rheumatism, clinical western medicine usually uses non-paralytic anti-inflammatory drugs (NSAIDs) to control inflammation and improve symptoms.

For patients with frequent symptoms and the use of NSAIDs on their own, consideration could be given to the use of anti-generatives (DMARDs), such as hydroxychloroquine sulphate, nitrous sulfide, etc. However, due to the absence of any symptoms during the mitigation period and the more adverse effects of DMARDs, many patients cannot accept long-term medication.

In contrast, Chinese doctors have accumulated extensive experience in the treatment of retraced rheumatism. According to Chinese medicine, retraced rheumatism falls within the category of “oppression” in the certificate, which is characterized by a marked red and red corrosive pain, a sudden onset of the disease and a period of time, with the removation of parts. “The man is in the blood of his blood, above him, below him, not to his left or his left.”

In the view of Chinese doctors, retraced rheumatism is mainly wind-based, forcing other outside evils into the human body, leading to closed circuits and poor flow of blood, which causes joint pain. In the case of treatment, emphasis is placed on the identification of treatments, which are based on the use of individualized treatments based on the body and condition of different patients, mainly in the form of wind, protruding and renal spleen.

In recent years, the clinical use of combination medical treatment in China and West has produced significant therapeutic results, not only in the rapid alleviation of the symptoms of joint pain and in the reduction of the adverse effects of drugs, but also in the effective reduction of the number of cases of disease through long-term management, which has gradually stabilized the situation.

Carnation: This is based on the sharing of diseases and is not a substitute for hospital visits. Comments are for reference purposes only, and medical advice is required for specific treatments.

References:

[1] Progress in diagnosis and treatment of rheumatism [J]. Internal medicine theory and practice, 2022, 17 (03): 258-261.[2] Progress in the treatment of rheumatism [J]. Rheumatism and arthritis [J], 2020, 9 (11): 66-68.[3] Lee Ying, Li Jing, Wang Lixa, et. et al.